Joanne G Wildenbeest, Marie-Noëlle Billard, Roy P Zuurbier, Koos Korsten, Annefleur C Langedijk, Peter M van de Ven, Matthew D Snape, Simon B Drysdale, Andrew J Pollard, Hannah Robinson, Terho Heikkinen, Steve Cunningham, Thomas O'Neill, Bishoy Rizkalla, Ana Dacosta-Urbieta, Federico Martinón-Torres, Marlies A van Houten, Louis J Bont
BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants. The burden of RSV infection in healthy term infants has not yet been established. Accurate health-care burden data in healthy infants are necessary to determine RSV immunisation policy when RSV immunisation becomes available. METHODS: We performed a multicentre, prospective, observational birth cohort study in healthy term-born infants (≥37 weeks of gestation) in five sites located in different European countries to determine the health-care burden of RSV...
November 10, 2022: Lancet Respiratory Medicine